Abstract 6781: First in class catalytic inhibitor of KAT2A/B demonstrates anti-tumor activity in multiple myeloma
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Kristen Jensen-Pergakes, Shawn O'Connell, Sacha Ninkovic, Natalie Miller, Clifford Restaino, Alok Ranjan, Sara Linker, Dana J. Ramms, Hieu Lam, Allison Rohner, Parsa Alan, Ravi Visswanathan, Eric C. Greenwald, Patrick Shelton, Daniel Sandoval, Jacqui Hoffman, Joyann Donaldson, Gwenaella Rescourio, Keith Abayasiriwardana, Akshata Udyavar, Thomas A. Paul
Institution: Pfizer (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148681793
Cites:
Cited by:
Related to: